tiprankstipranks
Advertisement
Advertisement
Eloxx Pharmaceuticals Reprices CEO Stock Options
PremiumCompany AnnouncementsEloxx Pharmaceuticals Reprices CEO Stock Options
2y ago
Eloxx Pharmaceuticals provides ELX-02, ZKN-013 program updates
Premium
The Fly
Eloxx Pharmaceuticals provides ELX-02, ZKN-013 program updates
2y ago
Eloxx Pharmaceuticals treatment of Alport Syndrome granted FDA orphan status
Premium
The Fly
Eloxx Pharmaceuticals treatment of Alport Syndrome granted FDA orphan status
2y ago
Eloxx Pharmaceuticals price target lowered to $30 from $60 at Oppenheimer
PremiumThe FlyEloxx Pharmaceuticals price target lowered to $30 from $60 at Oppenheimer
3y ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3y ago
Eloxx Pharmaceuticals reports results of patient biopsy assessment by NIPOKA
Premium
The Fly
Eloxx Pharmaceuticals reports results of patient biopsy assessment by NIPOKA
3y ago
Eloxx Pharmaceuticals reports Q2 EPS ($1.96) vs ($4.90) last year
PremiumThe FlyEloxx Pharmaceuticals reports Q2 EPS ($1.96) vs ($4.90) last year
3y ago
Eloxx Pharmaceuticals reports drug response in all patients treated with ELX-02
Premium
The Fly
Eloxx Pharmaceuticals reports drug response in all patients treated with ELX-02
3y ago
Eloxx Pharmaceuticals granted extension by Nasdaq to regain compliance
Premium
The Fly
Eloxx Pharmaceuticals granted extension by Nasdaq to regain compliance
3y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100